UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB ) Receptor Antagonist, Rimonabant (SR141716)

Neuropsychopharmacology (New York, N.Y.), 2005-01, Vol.30 (1), p.145-155

2005

Link zum Volltext

Verfügbarkeit prüfen

CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

The FASEB journal, 2005-09, Vol.19 (11), p.1567-1569

2005

Link zum Volltext

Verfügbarkeit prüfen

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Hepatology (Baltimore, Md.), 2007-07, Vol.46 (1), p.122-129

2007

Link zum Volltext

Verfügbarkeit prüfen

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Neuroscience letters, 2003-06, Vol.343 (3), p.216-218

2003

Link zum Volltext

Verfügbarkeit prüfen

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

Current pharmaceutical design, 2005-05, Vol.11 (12), p.1549

2005

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

Psychopharmacologia, 1997-07, Vol.132 (1), p.104-106

1997

Link zum Volltext

Verfügbarkeit prüfen

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

FEBS letters, 1994-08, Vol.350 (2), p.240-244

1994

Link zum Volltext

Verfügbarkeit prüfen

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Link zum Volltext

Verfügbarkeit prüfen

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

Brain research, 2002-10, Vol.953 (1), p.63-72

2002

Link zum Volltext

Verfügbarkeit prüfen

Blockade by the cannabinoid CBI receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

Neuropsychopharmacology (New York, N.Y.), 2004-05, Vol.29 (5), p.911-920

2004

Link zum Volltext

Verfügbarkeit prüfen

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2003-02, Vol.284 (2), p.345-R353

2003

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

European journal of pharmacology, 1993-12, Vol.250 (3), p.403-413

1993

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery

Neuroscience and biobehavioral reviews, 2001-12, Vol.25 (7-8), p.619-626

2001

Link zum Volltext

Verfügbarkeit prüfen

EFFECTS OF CB1 CANNABINOID RECEPTOR BLOCKADE ON ETHANOL PREFERENCE AFTER CHRONIC ALCOHOL ADMINISTRATION COMBINED WITH REPEATED RE-EXPOSURES AND WITHDRAWALS

Alcohol and alcoholism (Oxford), 2004-11, Vol.39 (6), p.486-492

2004

Link zum Volltext

Verfügbarkeit prüfen

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

Life sciences (1973), 1996, Vol.58 (6), p.PL103-PL110

1996

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

Naunyn-Schmiedeberg's archives of pharmacology, 1995-11, Vol.352 (5), p.576-579

1995

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

The Journal of physiology, 1998-08, Vol.510 (3), p.867-879

1998

Link zum Volltext

Verfügbarkeit prüfen

Expression of tachykinin NK2 receptor mRNA in human brain

Neuroscience letters, 2001-04, Vol.303 (1), p.25-28

2001

Link zum Volltext

Verfügbarkeit prüfen

Specific involvement of neurotensin type 1 receptor in the neurotensin‐mediated in vivo dopamine efflux using knock‐out mice

Journal of neurochemistry, 2004-04, Vol.89 (1), p.1-6

2004

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons

Journal of neurophysiology, 2000-06, Vol.83 (6), p.3287-3293

2000

Link zum Volltext

Verfügbarkeit prüfen

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Link zum Volltext

Verfügbarkeit prüfen

Effects of SR48968, a selective non-peptide NK 2 receptor antagonist on emotional processes in rodents

Psychopharmacology, 2001-11, Vol.158 (3), p.241-251

2001

Link zum Volltext

Verfügbarkeit prüfen

The new neurokinin 1‐sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA‐evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum

Journal of neurochemistry, 2003-10, Vol.87 (2), p.487-496

2003

Link zum Volltext

Verfügbarkeit prüfen

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair

The Journal of pharmacology and experimental therapeutics, 2002-06, Vol.301 (3), p.1067

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(124)
Buchkapitel
(1)

Sprache

Englisch
(125)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Animals
(95)
Science & Technology
(87)
Life Sciences & Biomedicine
(84)
Male
(73)
Rats
(70)
Biological And Medical Sciences
(57)
Pharmacology & Pharmacy
(50)
Neurosciences
(43)
Neurosciences & Neurology
(43)
Mice
(38)
Medical Sciences
(36)
Rats, Sprague-Dawley
(36)
Piperidines - Pharmacology
(35)
Pharmacology. Drug Treatments
(28)
Neuropharmacology
(27)
Psychology. Psychoanalysis. Psychiatry
(25)
Pyrazoles - Pharmacology
(23)
Humans
(22)
Fundamental And Applied Biological Sciences. Psychology
(21)
Dose-Response Relationship, Drug
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB ) Receptor Antagonist, Rimonabant (SR141716)

CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

Blockade by the cannabinoid CBI receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery

EFFECTS OF CB1 CANNABINOID RECEPTOR BLOCKADE ON ETHANOL PREFERENCE AFTER CHRONIC ALCOHOL ADMINISTRATION COMBINED WITH REPEATED RE-EXPOSURES AND WITHDRAWALS

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

Expression of tachykinin NK2 receptor mRNA in human brain

Specific involvement of neurotensin type 1 receptor in the neurotensin‐mediated in vivo dopamine efflux using knock‐out mice

Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Effects of SR48968, a selective non-peptide NK 2 receptor antagonist on emotional processes in rodents

The new neurokinin 1‐sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA‐evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair

Suchergebnisse filtern